Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group.

BACKGROUND Osteoporotic fractures, including clinically detected vertebral fractures, are associated with increased mortality. However, only one third of vertebral fractures are diagnosed. It is unknown whether vertebral fractures, whether clinically apparent or not, are associated with greater mortality. OBJECTIVES To test the hypothesis that women with prevalent vertebral fractures have greater mortality than those without fractures and to describe causes of death associated with vertebral fractures. DESIGN Prospective cohort study with mean follow-up of 8.3 years. SETTING Four clinical centers in the United States. PARTICIPANTS A total of 9575 women aged 65 years or older and enrolled in the Study of Osteoporotic Fractures. MEASUREMENTS Vertebral fractures by radiographic morphometry; calcaneal bone mineral density; demographic, medical history, and lifestyle variables; blood pressure; and anthropometric measures. In a subset of 606 participants, thoracic curvature was measured during a second clinic visit. MAIN OUTCOME MEASURES Hazard ratios for mortality and cause-specific mortality. RESULTS At baseline, 1915 women (20.0%) were diagnosed as having vertebral fractures. Compared with women who did not have a vertebral fracture, women with 1 or more fractures had a 1.23-fold greater age-adjusted mortality rate (95% confidence interval, 1.10-1.37). Mortality rose with greater numbers of vertebral fractures, from 19 per 1000 woman-years in women with no fractures to 44 per 1000 woman-years in those with 5 or more fractures (P for trend, <.001). In particular, vertebral fractures were related to the risk of subsequent cancer (hazard ratio, 1.4;95% confidence interval, 1.1-1.7) and pulmonary death (hazard ratio, 2.1;95% confidence interval, 1.4-3.0). In the subset of women who underwent thoracic curvature measurements, severe kyphosis was also related to pulmonary deaths (hazard ratio, 2.6;95% confidence interval, 1.3-5.1). CONCLUSION Women with radiographic evidence of vertebral fractures have an increased mortality rate, particularly from pulmonary disease and cancer.

[1]  S. Cummings,et al.  A new approach to defining normal vertebral dimensions , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  C. Cooper,et al.  Incidence of clinically diagnosed vertebral fractures: A population‐based study in rochester, minnesota, 1985‐1989 , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  T. Bringman,et al.  Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. , 1987, The New England journal of medicine.

[4]  G. Mundy.  Role of cytokines in bone resorption , 1993, Journal of cellular biochemistry.

[5]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[6]  D. Kiel.  Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures. , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  S. Ralston,et al.  Nitric oxide and bone , 2001, Immunology.

[8]  S. H. Kan,et al.  Epidemiology of vertebral fractures in women. , 1989, American journal of epidemiology.

[9]  C. Dulberg,et al.  Relationship of lung function to severity of osteoporosis in women. , 1990, The American review of respiratory disease.

[10]  H K Genant,et al.  Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. , 1990, JAMA.

[11]  T. Lohman,et al.  Anthropometric Standardization Reference Manual , 1988 .

[12]  S. Moncada,et al.  The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.

[13]  J. Brody,et al.  Race and sex differences in mortality following fracture of the hip. , 1992, American journal of public health.

[14]  T. M. Kashner,et al.  Survival experience of aged hip fracture patients. , 1989, American journal of public health.

[15]  D. Wallwiener,et al.  Reduction in new metastases in breast cancer with adjuvant clodronate treatment. , 1998, The New England journal of medicine.

[16]  Harry K. Genant,et al.  Appendicular Bone Density and Age Predict Hip Fracture in Women , 1990 .

[17]  E. Fisher,et al.  Treatment and survival among elderly Americans with hip fractures: a population-based study. , 1994, American journal of public health.

[18]  P. W. Johnston,et al.  Nitric oxide: A cytokine‐induced regulator of bone resorption , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  L. Raisz,et al.  Local and systemic factors in the pathogenesis of osteoporosis. , 1988, World review of nutrition and dietetics.

[20]  P. Collin‐Osdoby,et al.  Bone cell function, regulation, and communication: A role for nitric oxide , 1995, Journal of cellular biochemistry.

[21]  S. Cummings,et al.  Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis , 1996 .

[22]  Robert Epstein,et al.  Comparison of methods for defining prevalent vertebral deformities: The study of osteoporotic fractures , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  C. Cooper,et al.  Population-based study of survival after osteoporotic fractures. , 1993, American journal of epidemiology.

[24]  Michael C. Nevitt,et al.  Mortality Following Fractures in Older Women: The Study of Osteoporotic Fractures , 1996 .

[25]  S. Cummings,et al.  Non-trauma mortality in elderly women with low bone mineral density , 1991, The Lancet.